CatalystWireBeta

Crism Therapeutics Corporation

CRTX · AIM · Health Care · mcap £7.4m · 9.0p

Beta Briefing, track record and bull & bear case are not ready for Crism Therapeutics Corporation yet.

We follow 817 UK small caps and every one of their announcements – often hundreds per company. 37 companies are already wired into a briefing: browse them.

Premier Miton Group plc 16 Jun · 1 notice
below 3% → 9.5%
share price at the notices 10.5p · now 9.0p 16 Jun 2026
Spreadex LTD 27 Nov – 29 Jul · 4 notices
3.1% → 3.5%
share price at the notices 9.5–12.0p · now 9.0p 27 Nov 2025 22 Jun 2026 2 Jul 2026 29 Jul 2026

Directors

No open-market share purchases by directors in 12 months.

other CRISM Therapeutics Corporation announces the resignation of Dr. Nermeen Varawalla from the Board of Directors, who served as Non-Executive Chair since the company's AIM listing in May 2024. Andrew Webb will continue as I 2 Apr 2026

Company filings. Not investment advice.

Share this quote

Quote card
Post on X WhatsApp Download image

The link opens this announcement with the quote highlighted. Quotes are checked against the original text.

Add a note